Financials
Financial year 2025
Gross margin
€ 1.1 million
▲ 40% vs 2024
Profit
Growing€ 377,447
▲ 116% vs 2024
Debts
High€ 4.3 million
▼ 21% vs 2024
Orifarm Belgium from Gent, company number BE0736472401, closed financial year 2025 with a result of € 377,447 after tax. For that financial year Orifarm Belgium recorded a gross margin of € 1.1 million and equity of € 729,475. Compared with financial year 2024, the result moved from € 175,053 to € 377,447. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
What happened at Orifarm Belgium?
What happened at Orifarm Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 377,447 (▲ 116% vs 2024). Source: NBB ↗
- Nicki Lund Kristensen became a director. NBB
- Mads Fink Eriksen became a director. NBB
- Hans Carl Boegh-Soerensen became a director. NBB
- New establishment in Gent. KBO
- Thomas Brandhof became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 37,205 profit in 2021 to € 377,447 profit in 2025.
Paid € 260,146 in corporate taxes since 2021.
Best year ever: 2025, with € 377,447 profit.
On average € 390,600 of value added per employee in 2025.
A new publication or filing at Orifarm Belgium? We notify you, reason included.
Follow Orifarm BelgiumNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Orifarm Belgium are Thomas Brandhof, Nicki Lund Kristensen, Mads Fink Eriksen and Hans Carl Boegh-Soerensen. The same people are also behind Affordable Medicines Europe and Orifarm Healthcare.
Directors
According to the 2025 annual accounts
since 2019
since 2025
since 2025
since 2025
Establishments
Establishment units
Physical locations of this company
Gaston Crommenlaan 8
9050 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 68 companies are registered at this address.
ELDEMAR
€ 4.8 million gross margin · 2025
Petanque Mouscron
Iptor Belgium
€ 6.2 million revenue · 2025
1Enclose
€ 43,088 gross margin · 2025
FLUKE BELGIUM
€ 11.4 million revenue · 2025
+63 more
Details
- Company number
- 0736.472.401
- VAT number
- BE 0736.472.401
- Registered office
- Gaston Crommenlaan 8, 9050 Gent
- Names & denominations
- Orifarm Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 October 2019
- Peppol
- Active · Active since 11 Jun 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen